Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
panax notoginseng granules
- Development stage
- Unknown
- Lead developer
- SU BioMedicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Panax notoginseng granules, marketed under the brand name **MetaFlow** by **SU BioMedicine**, is a botanical product derived from the roots of *Panax notoginseng*. It was registered as a food supplement in the European Union in 2024. *Panax notoginseng* is a traditional Chinese medicinal herb known for its bioactive saponins, specifically notoginsenosides, which are associated with hemostatic, anti-inflammatory, and cardiovascular benefits. The granule formulation is intended for oral administration to support metabolic health and blood circulation.
- Brand names
- MetaFlow
- Other names
- Panax notoginsengSanqiTienchi ginsengNotoginseng Radix
02
Targets
PLCG2 (Phospholipase C gamma 2)PPARG (Peroxisome proliferator-activated receptor gamma)GP1BA (Platelet glycoprotein ib alpha chain)P2Y12 (Purinergic P2Y12 receptor)
Beyond the preview
Go deeper on panax notoginseng granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on panax notoginseng granules.